Browsing publications by Dr David Jamieson

Newcastle AuthorsTitleYear
Christopher Hill
Dr David Jamieson
Huw Thomas
Dr Colin Brown
Professor Alan Boddy
et al.
Characterisation of the roles of ABCB1, ABCC1, ABCC2 and ABCG2 in the transport and pharmacokinetics of actinomycin D in vitro and in vivo2013
Professor Ann Daly
Dr Gareth Veal
Dr David Jamieson
Dr Sally Coulthard
Pharmacogenomics research at Newcastle University2012
Dr Jane Armstrong
Shaun Martin
Nicola Illingworth
Dr David Jamieson
Dr Penny Lovat
et al.
The impact of retinoic acid treatment on the sensitivity of neuroblastoma cells to fenretinide2012
Dr Sophie Weatherhead
Professor Peter Farr
Dr David Jamieson
Dr Jennifer Hallinan
Dr James Lloyd
et al.
Apoptosis of keratinocytes is a key mechanism in UVB-induced clearance of psoriasis2011
Dr Sophie Weatherhead
Professor Peter Farr
Dr David Jamieson
Dr Jennifer Hallinan
Dr James Lloyd
et al.
Keratinocyte Apoptosis in Epidermal Remodeling and Clearance of Psoriasis Induced by UV Radiation2011
Dr David Jamieson
Professor Alan Boddy
Pharmacogenetics of genes across the doxorubicin pathway2011
Dr David Jamieson
Dr Nicola Cresti
Julieann Sludden
Melanie Griffin
Nahed Hawsawi
et al.
Two minor NQO1 and NQO2 alleles predict poor response of breast cancer patients to adjuvant doxorubicin and cyclophosphamide therapy2011
Julieann Sludden
Melanie Griffin
Mike Cole
Dr Mark Verrill
Dr David Jamieson
et al.
Influence of pharmacogenetics on response and toxicity in breast cancer patients treated with doxorubicin and cyclophosphamide2010
Dr Nicola Cresti
Dr David Jamieson
The pharmacology of trastuzumab and its use in breast cancer2010
Dr David Jamieson
Dr Nicola Cresti
Dr Mark Verrill
Professor Alan Boddy
Development and validation of cell-based ELISA for the quantification of trastuzumab in human plasma2009
12